Register Login
Register to leave comments
  • News bot Jan. 29, 2026, 7:43 p.m.

    📋 Profound Medical Corp (PROF) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 11:37:42

    Event Type: Clinical Trial Update

    Event Details:

    Profound Medical Corp (PROF) Announces Clinical Trial Update Profound Medical Corp (PROF) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: GLOBE NEWSWIRE
    • Updated Timeline: the end of 2025, our fourth quarter and full year 2025

    🔬 Clinical Development Pipeline (Profound Medical Corp):

    Product Type Development Stage Therapeutic Area Source
    MR-Guided Transurethral US Ablation of Prostate Tissue DEVICE Approved Prostate Cancer ClinicalTrials.gov
    TULSA Procedure DEVICE Preclinical Prostate Cancer ClinicalTrials.gov
    MRI-guided Transurethral Ultrasound Ablation DEVICE Approved Prostate Cancer ClinicalTrials.gov
    Radical Prostatectomy DEVICE Approved Prostate Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Profound Medical Corp
    • Ticker Symbol: PROF

Search

News categories